NAS:INGN (USA) Also trade in: Germany

Inogen Inc

$ 71.13 0 (0%)
Volume: 387,341 Avg Vol (1m): 579,045
Market Cap $: 1.56 Bil Enterprise Value $: 1.32 Bil
P/E (TTM): 34.64 P/B: 4.82
Earnings Power Value 25.9
Net Current Asset Value 11.34
Tangible Book 14.04
Projected FCF 26.61
Median P/S Value 107.56
Graham Number 25.51
Peter Lynch Value 33.72
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 9/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt No Debt
Cash-To-Debt ranked higher than
83.64% of 330 companies
in the Medical Devices industry.
Industry Max: 504099, Med: 2.32, Min: -16.34
INGN: No Debt
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.41, Med: 361.74, Max: 10000
Current: 10000
0.41
10000
Equity-to-Asset 0.83
Equity-to-Asset ranked higher than
81.23% of 309 companies
in the Medical Devices industry.
Industry Max: 0.99, Med: 0.63, Min: -24.4
INGN: 0.83
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: -1.7, Med: 0.82, Max: 0.85
Current: 0.83
-1.7
0.85
Interest Coverage No Debt
Interest Coverage ranked higher than
83.02% of 212 companies
in the Medical Devices industry.
Industry Max: 10000, Med: 66.37, Min: 0.03
INGN: No Debt
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 1.68, Med: 684.14, Max: 10000
Current: 10000
1.68
10000
Piotroski F-Score 7
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 16.53
DISTRESS
GREY
SAFE
Beneish M-Score -2.17
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 63.68%
WACC 13.56%

Profitability & Growth : 8/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 9.22
Operating Margin ranked higher than
72.44% of 312 companies
in the Medical Devices industry.
Industry Max: 1148.46, Med: 1.96, Min: -47867.72
INGN: 9.22
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: -5.62, Med: 9.41, Max: 11.27
Current: 9.22
-5.62
11.27
Net Margin % 12.56
Net Margin ranked higher than
71.79% of 312 companies
in the Medical Devices industry.
Industry Max: 15538.12, Med: 1.4, Min: -45900
INGN: 12.56
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: -6.54, Med: 7.86, Max: 33.71
Current: 12.56
-6.54
33.71
ROE % 16.14
ROE ranked higher than
73.03% of 304 companies
in the Medical Devices industry.
Industry Max: 51.97, Med: 0.95, Min: -2921.66
INGN: 16.14
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: 9.19, Med: 12.98, Max: 19.29
Current: 16.14
9.19
19.29
ROA % 13.23
ROA ranked higher than
83.43% of 332 companies
in the Medical Devices industry.
Industry Max: 1204.95, Med: -0.26, Min: -2520.55
INGN: 13.23
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: -8.3, Med: 8.14, Max: 39.14
Current: 13.23
-8.3
39.14
ROC (Joel Greenblatt) % 73.87
ROC (Joel Greenblatt) ranked higher than
89.30% of 327 companies
in the Medical Devices industry.
Industry Max: 8175, Med: 3.87, Min: -323166.67
INGN: 73.87
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: -13.45, Med: 29.92, Max: 93.23
Current: 73.87
-13.45
93.23
3-Year Total Revenue Growth Rate 31.10
3-Year Revenue Growth Rate ranked higher than
86.61% of 254 companies
in the Medical Devices industry.
Industry Max: 300.7, Med: 4.3, Min: -100
INGN: 27.5
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: 22.2, Med: 32, Max: 49.3
Current: 27.5
22.2
49.3
3-Year Total EBITDA Growth Rate 21.60
3-Year EBITDA Growth Rate ranked higher than
59.05% of 232 companies
in the Medical Devices industry.
Industry Max: 109.5, Med: 7.5, Min: -344.2
INGN: 18.3
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: 15.2, Med: 33.8, Max: 140.5
Current: 18.3
15.2
140.5
3-Year EPS w/o NRI Growth Rate 60.10
3-Year EPS w/o NRI Growth Rate ranked higher than
89.24% of 223 companies
in the Medical Devices industry.
Industry Max: 241, Med: 7.8, Min: -413
INGN: 60.1
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 47.4, Max: 141
Current: 60.1
0
141

» INGN's 30-Y Financials

Financials (Next Earnings Date: 2019-08-07)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:INGN

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Devices » Medical Devices    NAICS : 325412    SIC : 3842
Compare NYSE:NVRO XSWX:MOVE TSE:3360 TSE:8086 SZSE:300633 XSWX:YPSN NAS:CNMD OCSE:OSSR NYSE:ITGR HKSE:00853 TSE:7817 TSE:6849 TSE:7575 NAS:CSII NAS:SILK SZSE:002317 NYSE:INSP XSWX:TECN NAS:SWAV SZSE:300326
Traded in other countries 6IO.Germany
Address 326 Bollay Drive, Goleta, CA, USA, 93117
Inogen Inc is a medical technology company that develops and manufactures portable oxygen concentrators used to deliver oxygen therapy to patients with chronic respiratory conditions. Its key product, the Inogen One system, is a lightweight alternative to traditional, stationary oxygen concentrator systems and oxygen tanks. The firm sells its products to home medical equipment providers and also rents products directly to patients. The majority of rental revenue comes from Medicare service reimbursement programs. Internationally, Inogen sells its products through distributors or large gas companies and home oxygen providers. Inogen generates the majority of its revenue in the United States.

Ratios

Current vs industry vs history
PE Ratio (TTM) 34.64
PE Ratio ranked lower than
93.33% of 180 companies
in the Medical Devices industry.
Industry Max: 8940, Med: 30.17, Min: 0.06
INGN: 34.64
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 1.87, Med: 76.73, Max: 185.25
Current: 34.64
1.87
185.25
PE Ratio without NRI 34.64
PE without NRI ranked lower than
93.30% of 179 companies
in the Medical Devices industry.
Industry Max: 8940, Med: 30.17, Min: 0.06
INGN: 34.64
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 1.87, Med: 76.73, Max: 185.25
Current: 34.64
1.87
185.25
Price-to-Owner-Earnings 725.72
Price-to-Owner-Earnings ranked lower than
92.31% of 104 companies
in the Medical Devices industry.
Industry Max: 10850, Med: 32.03, Min: 0.73
INGN: 725.72
Ranked among companies with meaningful Price-to-Owner-Earnings only.
Price-to-Owner-Earnings range over the past 10 years
Min: 130.17, Med: 211.23, Max: 1091.53
Current: 725.72
130.17
1091.53
PB Ratio 4.82
PB Ratio ranked lower than
91.29% of 310 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 3.06, Min: 0.07
INGN: 4.82
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 2.39, Med: 7.31, Max: 21.16
Current: 4.82
2.39
21.16
PS Ratio 4.36
PS Ratio ranked lower than
80.95% of 294 companies
in the Medical Devices industry.
Industry Max: 1136.36, Med: 3.15, Min: 0.05
INGN: 4.36
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 2.35, Med: 6.57, Max: 19.07
Current: 4.36
2.35
19.07
Price-to-Free-Cash-Flow 46.12
Price-to-Free-Cash-Flow ranked lower than
74.77% of 107 companies
in the Medical Devices industry.
Industry Max: 3239, Med: 26.44, Min: 5.07
INGN: 46.12
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 24.33, Med: 56.39, Max: 222.06
Current: 46.12
24.33
222.06
Price-to-Operating-Cash-Flow 34.92
Price-to-Operating-Cash-Flow ranked lower than
81.10% of 127 companies
in the Medical Devices industry.
Industry Max: 1586.78, Med: 20.01, Min: 3.03
INGN: 34.92
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 16.35, Med: 41.37, Max: 104.55
Current: 34.92
16.35
104.55
EV-to-EBIT 36.08
EV-to-EBIT ranked lower than
92.53% of 174 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 24.76, Min: 0.63
INGN: 36.08
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: 16.2, Med: 60, Max: 153.2
Current: 36.08
16.2
153.2
EV-to-EBITDA 27.72
EV-to-EBITDA ranked lower than
92.02% of 188 companies
in the Medical Devices industry.
Industry Max: 18456.56, Med: 18.14, Min: 0.62
INGN: 27.72
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: 5.7, Med: 34.75, Max: 119.1
Current: 27.72
5.7
119.1
EV-to-Revenue 3.63
EV-to-Revenue ranked lower than
75.08% of 309 companies
in the Medical Devices industry.
Industry Max: 17078.6, Med: 3.73, Min: 0.05
INGN: 3.63
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 1, Med: 6.1, Max: 18.6
Current: 3.63
1
18.6
PEG Ratio 1.50
PEG Ratio ranked lower than
100.00% of 77 companies
in the Medical Devices industry.
Industry Max: 804, Med: 2.53, Min: 0.14
INGN: 1.5
Ranked among companies with meaningful PEG Ratio only.
PEG Ratio range over the past 10 years
Min: 1.5, Med: 3.69, Max: 7.6
Current: 1.5
1.5
7.6
Current Ratio 7.35
Current Ratio ranked higher than
87.35% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.71, Min: 0.03
INGN: 7.35
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 1.14, Med: 5.16, Max: 7.35
Current: 7.35
1.14
7.35
Quick Ratio 6.70
Quick Ratio ranked higher than
88.89% of 324 companies
in the Medical Devices industry.
Industry Max: 563.8, Med: 2.03, Min: 0.02
INGN: 6.7
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.96, Med: 4.68, Max: 6.7
Current: 6.7
0.96
6.7
Days Inventory 54.31
Days Inventory ranked higher than
87.07% of 294 companies
in the Medical Devices industry.
Industry Max: 990.33, Med: 143.61, Min: 0.63
INGN: 54.31
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 35.87, Med: 40.68, Max: 54.31
Current: 54.31
35.87
54.31
Days Sales Outstanding 41.05
Days Sales Outstanding ranked higher than
83.70% of 276 companies
in the Medical Devices industry.
Industry Max: 907.73, Med: 69.21, Min: 0.13
INGN: 41.05
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 37.75, Med: 50.78, Max: 62.76
Current: 41.05
37.75
62.76
Days Payable 28.76
Days Payable ranked lower than
80.08% of 261 companies
in the Medical Devices industry.
Industry Max: 912.5, Med: 58.34, Min: 1
INGN: 28.76
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 19.85, Med: 37.91, Max: 131.45
Current: 28.76
19.85
131.45

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -4.40
3-Year Share Buyback Rate ranked higher than
53.69% of 244 companies
in the Medical Devices industry.
Industry Max: 19.2, Med: -5.7, Min: -1393.3
INGN: -4.4
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -6.6, Med: -4.4, Max: -3.3
Current: -4.4
-6.6
-3.3

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 5.07
Price-to-Tangible-Book ranked lower than
83.33% of 276 companies
in the Medical Devices industry.
Industry Max: 1180, Med: 4.5, Min: 0.07
INGN: 5.07
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 2.79, Med: 7.33, Max: 18.42
Current: 5.07
2.79
18.42
Price-to-Projected-FCF 2.67
Price-to-Intrinsic-Value-Projected-FCF ranked lower than
100.00% of 121 companies
in the Medical Devices industry.
Industry Max: 89.64, Med: 2.44, Min: 0.43
INGN: 2.67
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 2.34, Med: 7.35, Max: 10.44
Current: 2.67
2.34
10.44
Price-to-Median-PS-Value 0.66
Price-to-Median-PS-Value ranked lower than
84.39% of 237 companies
in the Medical Devices industry.
Industry Max: 20.13, Med: 1.02, Min: 0.02
INGN: 0.66
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.42, Med: 1.02, Max: 2.48
Current: 0.66
0.42
2.48
Price-to-Peter-Lynch-Fair-Value 2.11
Price-to-Peter-Lynch-Fair-Value ranked lower than
100.00% of 47 companies
in the Medical Devices industry.
Industry Max: 26.18, Med: 2.05, Min: 0.43
INGN: 2.11
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 1.85, Med: 4.1, Max: 6.35
Current: 2.11
1.85
6.35
Price-to-Graham-Number 2.79
Price-to-Graham-Number ranked lower than
93.98% of 133 companies
in the Medical Devices industry.
Industry Max: 59.6, Med: 2.11, Min: 0.06
INGN: 2.79
Ranked among companies with meaningful Price-to-Graham-Number only.
Price-to-Graham-Number range over the past 10 years
Min: 0.52, Med: 4.79, Max: 10.45
Current: 2.79
0.52
10.45
Earnings Yield (Joel Greenblatt) % 2.74
Earnings Yield (Greenblatt) ranked higher than
52.11% of 332 companies
in the Medical Devices industry.
Industry Max: 158.73, Med: 0.74, Min: -2500
INGN: 2.74
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: 0.7, Med: 1.7, Max: 6.2
Current: 2.74
0.7
6.2
Forward Rate of Return (Yacktman) % 18.04
Forward Rate of Return ranked lower than
100.00% of 125 companies
in the Medical Devices industry.
Industry Max: 78.28, Med: 6.6, Min: -76.71
INGN: 18.04
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: 17.5, Med: 20.4, Max: 20.8
Current: 18.04
17.5
20.8

More Statistics

Revenue (TTM) (Mil) $ 369.26
EPS (TTM) $ 2.06
Beta 2.14
Volatility % 66.97
52-Week Range $ 62.32 - 287.79
Shares Outstanding (Mil) 21.93

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 7
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA N
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy Y